Explore the latest advances in alopecia areata treatment, including FDA-approved JAK inhibitors and promising topical ...

The global veterinary monoclonal antibodies market is set to surge, reaching USD 3.06 billion by 2030, up from USD 1.70 ...

FRIENDSWOOD, Texas, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its ...

Extended dosing of dupilumab in patients with AD has similar efficacy as standard dosing, with no significant affect seen on ocular adverse events.

Greater baseline disease pruritus and quality of life impairment are associated with higher rates of super response to dupilumab in patients with AD.

More than 31 million people in the U.S. live with eczema, a chronic skin condition that can disrupt daily life yet continues ...

Tori Spelling shares her and her family’s journey with eczema and seborrheic dermatitis to encourage others to take control of their skin healthZORYVE® (roflumilast) is the #1 prescribed branded ...

Once-daily, effective, safe, and well-tolerated ZORYVE cream 0.05% now commercially available for children as young as age 2ZORYVE cream 0.05% ...

Incyte (Nasdaq:INCY) today announced new data from the Phase 3b TRuE-AD4 study evaluating the efficacy and safety of Opzelura ® (ruxolitinib cream) in adults with moderate atopic dermatitis (AD) who ...

There are some 40 interleukins that play a wide variety of roles in inflammation and the body’s immune response, some of them hitting the accelerator and others tapping the brakes. When it comes to ...